Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-001343-31Phase 3Completed
Phase 3, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Consumption of opioids over the first 24 hours postoperatively. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-001343-31.